Skip to main content

Researches Our research spans a wide range from basic organic synthesis, drug design and development, structure elucidation of newly synthesized compound and natural products. The research focuses on the following strategic Research Themes: Design and synthesis of new chemical entities. Computer aided drug design studies. Structure-Activity relationship studies. Combinatorial chemistry. Prod rugs developments. Analytical methods for bioavailability and metabolic studies. Research within these Themes is carried out in multidisciplinary groupings focused on the discovery of novel techniques and/or enhancement of the already existing ones. At the department of Medicinal Pharmacy, We have major national and international collaborative research projects and a significant output of research publications in high-ranking journals. Our academic collaborators include many Universities in USA, Canada, Japan, and a number of major European universities.

# Title Research Year
241 Solution-Phase Synthesis of Small Schiff Bases Combinatorial Library with Potential Antitubercular Activity 2009
242 Solution-Phase Synthesis of Small Schiff Bases Combinatorial Library with Potential Antitubercular Activity 2009
243 Solution-Phase Synthesis of Small Schiff Bases Combinatorial Library with Potential Antitubercular Activity 2009
244 Synthesis and Investigation of Anti-Inflamma-tory Activity
and Gastric Ulcerogenicity of Novel Nitric Oxide-Donating
Pyrazoline Derivatives
2009
245 Synthesis and Investigation of Anti-Inflamma-tory Activity
and Gastric Ulcerogenicity of Novel Nitric Oxide-Donating
Pyrazoline Derivatives
2009
246 Synthesis of Some Pyrazolylbenzenesulfon-amide
Derivatives as Anti-Inflammatory Antimicrobial Agents
2009
247 THE PROTEOLYTIC STABILITY AND CYTOTOXICITY STUDIES OF L-ASPARTIC AND L-DIAMINOPROPIONIC ACID DERIVED OLIGOMERS 2009
248 The Proteolytic Stability and Cytotoxicity Studies of l‐Aspartic Acid and l‐Diaminopropionic Acid derived β‐Peptides and a Mixed α/β‐Peptide 2009
249 The trichloroethyl group as a protecting group for sulfonates and its application to the synthesis of a disulfonate analog of the tyrosine sulfated PSGL-1143−50 peptide 2009
250 BACE1 Inhibitors: Optimization by Replacing the P1’
Residue with Non-Acidic Moiety
2008